Current findings suggest that necroptotic cell death may be involved in multiple inflammatory diseases. Interfering in the cellular pathways leading to necrosis might thus be a valuable target for therapeutic intervention in these diseases, as an alternative for the current anti-TNF therapies, which have serious drawbacks. Therefore, this project will focus on the identification and validation of necroptosis inhibitors.